Please assess the completion status of the following clinical trial:

Trial Title: Opioid Prescription After Cesarean Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Post cesarean delivery (combined vaginal/cesarean deliveries are not eligible)~* Singleton, twin or triplet gestation~Exclusion Criteria:~* An opioid prescription filled during the current pregnancy~* Known history of opioid use disorder, by medical record review~* Contraindication to opioids (oxycodone)~* Contraindications to both acetaminophen and ibuprofen~* Significant surgical procedures (e.g., hysterectomy) prior to randomization as pain trajectory will be completely different~* Fetal or neonatal death prior to randomization~* Inability to randomize within 1 day before planned discharge from the hospital~* Inability to participate in shared decision making as assessed by research staff~* Language barrier (non-English or Spanish speaking)~* Participation in this trial in a previous pregnancy~* Participation in another intervention study that influences the primary outcome in this trial

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Individualized Opioid Prescription (Type: EXPERIMENTAL): Individualized opioid prescription protocol and shared decision making
- Fixed Opioid Prescription (Type: OTHER): Fixed opioid prescription of 20 tablets of oxycodone 5mg

Based on this trial design, predict the completion outcome and termination type (if applicable).